The effects of Ketoconazole on the pharmacokinetics of Cyclosporine A in cats

Veterinary Surgery

Volumn 28, Issue 6, 1999, Pages 448-455

  McAnulty, Jonathan F ^a   Lensmeyer, G L ^a  

^a Department of Surgical Sciences ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; KETOCONAZOLE;

ANIMAL; ANIMAL DISEASE; AREA UNDER THE CURVE; ARTICLE; CAT; CAT DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; DRUG INTERACTION; HALF LIFE TIME; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY TRANSPLANTATION; METABOLISM; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL;

ANIMALS; ANTIFUNGAL AGENTS; AREA UNDER CURVE; CAT DISEASES; CATS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOSPORINE; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; HALF-LIFE; IMMUNOSUPPRESSIVE AGENTS; KETOCONAZOLE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LINEAR MODELS; PROSPECTIVE STUDIES;

EID: 0033228408     PISSN: 01613499     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-950x.1999.00448.x     Document Type: Article

References (27)

1. Gregory CR, Gourley IM, Kochin EJ, et al: Renal transplantation for treatment of end-stage renal failure in cats. J Amer Vet Med Assoc 201:285-291, 1992
2. Gregory CR: Renal transplantation in cats. Comp Cont Educ 15:1325-1337, 1993
3. Baciewicz AM, Baciewicz FAJ: Cyclosporine pharmacokinetic drug interactions. Am J Surg 157:264-271, 1989
4. Watkins PB: The role of cytochromes P-450 in cyclosporine metabolism. J Am Acad Dermatol 23:1301-1309, 1990
5. Albengres E, Tillement JP: Cyclosporin and ketoconazole, drug interaction or therapeutic association? Int J Clin Pharmacol Ther Toxicol 30:555-570, 1992
6. Butman SM, Wild JC, Nolan PE, et al: Prospective study of the safety and financial benefit of ketoconazole as adjunctive therapy to cyclosporine after heart transplantation. J Heart Lung Transplant 10:351-358, 1991
7. D'mello A, Venkataramanan R, Satake M, et al: Pharmacokinetics of the cyclosporine-ketoconazole interaction in dogs. Res Commun Chem Pathol Pharmacol 64:441-454, 1989
8. First MR, Schroeder TJ, Alexander JW, et al: Cyclosporine dose reduction by ketoconazole administration in renal transplant recipients. Transplantation 51:365-370, 1991
9. First MR, Schroeder TJ, Michael A, et al: Cyclosporine-ketoconazole interaction. Long-term follow-up and preliminary results of a randomized trial. Transplantation 55:1000-1004, 1993
10. Myre SA, Schoeder TJ, Grund VR, et al: Critical ketoconazole dosage range for ciclosporih clearance inhibition in the dog. Pharmacology 43:233-241, 1991
11. Gregory CR, Hietla SK, Pedersen NC, et al: Cyclosporine pharmacokinetics in cats following topical ocular administration. Transplantation 47:516-519, 1989
12. Latimer KS, Rakich PM, Purswell BJ, et al: Effects of cyclosporin A administration in cats. Vet Immunol Immunopathol 11:161-173, 1986
13. Lensmeyer G, Wiebe D, Carlson I, et al: Concentrations of cyclosporin A and its metabolites in human tissue postmortem. J Analytical Toxicol 15:110-115, 1991
14. Gibaldi M, Perrier D: Pharmacokinetics (ed 2). New York, Dekker, 1982, pp 1-351
15. Sun S, Greensiein SM, Kim DY, et al: Nifedipine proiects small intestine from cyclosporine-induced hemodynamic and functional impairment. J Surg Res 69:295-299, 1997
16. Patton PR, Brunson ME, Pfaff WW, et al: A preliminary report of diltiazem and ketoconazole. Their cyclosporine-sparing effect and impact on transplant outcome. Transplantation 57:889-892, 1994
17. Freeman DJ: Pharmacology and pharmacokinetics of cyclosporine. Clin Biochem 24:9-14, 1991
18. Ptachcinski RJ, Venkataramanan R, Rosenthal JT, et al: Cyclosporine kinetics in renal transplantation. Clin Pharmacol Ther 38:296-300, 1985
19. Sangalli L, Bortolotti A, Jiritano L, et al: Cyclosporine pharmacokinetics in rats and interspecies comparison in dogs, rabbits, rats, and humans. Drug Metab Dispos Biol Fate Chem 16:749-753, 1988
20. Lampen A, Christians U, Bader A, et al: Drug interactions and interindividual variability of cyclosporin metabolism in the small intestine. Pharmacology 52:159-168, 1996
21. Vickers AE, Fischer V, Connors S, et al: Cyclosporin A metabolism in human liver, kidney, and intestine slices. Comparison to rat and dog slices and human cell lines. Drug Metab Dispos Biol Fate Chem 20:802-809, 1992
22. Yatscoff RW, Rosano TG, Bowers LD: The clinical significance of cyclosporine metabolites. Clin Biochem 24:23-35, 1991
23. First MR, Schroeder T, Weiskittel P, et al: Concommitant administration of cyclosporin and ketocozazole in renal transplant recipients. Lancet 2:1198-1201, 1989
24. Dahlinger J, Gregory C, Bea J: Effect of ketoconazole on cyclosporine dose in healthy dogs. Vet Surg 27:64-68, 1998
25. Gomez DY, Wacher VJ, Tomlanovich SJ, et al: The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine. Clin Pharmacol Ther 58:15-19, 1995.
26. Keogh A, Spratt P, McCosker C, et al: Ketoconazole to reduce the need for cyclosporine after cardiac transplantation. New Engl J Med 333:628-633, 1995
27. Badcock NR: Micro-determination of ketoconazole in plasma or serum by high-performance liquid chromatography. J Chromatog 306:436-440, 1984